MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by Barrheadon May 05, 2020 3:12pm

318 Views

Post# 30989322

RE:fda approval doesn't always mean a whole lot

Excuse me or my ignorance with the necessity of obtaining the FDA approval; It is IMO key to seeing this stock move forward by 2-3X from current price. More so there could be a buyout or takeover equating to a lucrative blue chip stock that pays dividends...Again just my opinion.

Regardzzz.........Barrhead

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features